World IBD Day is recognized on May 19 to raise awareness of inflammatory bowel disease (IBD) and the two conditions that comprise it: Crohn's disease and ulcerative colitis, both of which cause chronic inflammation of the gastrointestinal tract. World IBD Day is sponsored by the European Federation of Crohn's and Ulcerative Colitis Associations, which includes the Crohn's & Colitis Foundation.

© Springer International Publishing Switzerland 2016 R. K. Cross, A. R. Watson (eds.), Telemanagement of Inflammatory Bowel Disease, DOI 10.1007/978-3-319-22285-1_11 W. K. van Deen () · D. W. Hommes UCLA Center for Inflammatory Bowel Diseases, Melvin and Bren Simon Digestive Diseases Center, David Geffen School of Medicine, University of California, 10945 Le Conte Ave PVUB #2338E, Los Angeles,...

Inflammatory bowel disease (IBD) is a chronic nonspecific intestinal inflammatory disease, including ulcerative colitis (UC) and Crohn's disease (CD). Its pathogenesis remains not yet clear. Current researchers believe that after environmental factors act on individuals with genetic susceptibility, an abnormal intestinal immune response is launched under stimulation of intestinal flora. However...

     Inflammatory bowel disease (IBD) is an irregular response of immune system accompanied with different inflammatory manifestations including alterations in cytokines. Probiotics are non-pathogenic organisms with probable effects in various conditions such as inflammation. The present study hypothesized whether oral intake of bifidobacterium and lactobacillus in form of probiotic yogurt may ...

BACKGROUND: Inflammatory bowel disease (IBD) refers to two chronic inflammatory disorders of the gastrointestinal tract which is generally believed to be rare in most African countries. The objectives of the current study were to present the experience of three tertiary gastroenterology centers in southern part of Nigeria on IBD, highlighting the age distribution of the patients seen, managemen...

BACKGROUND Incidences of colorectal cancer (CRC) and inflammatory bowel disease (IBD) are increasing in those aged <50 years. AIM To identify and quantify clinical features in primary care of CRC/IBD in those aged <50 years. This study considered the two conditions together and aimed to determine which younger patients, presenting in primary care with symptoms, would benefit from investigatio...

Inflammatory bowel disease (IBD) is a group of conditions that affect the gastrointestinal system. IBD consists of autoimmune diseases that attack the GI mucosa, resulting in inflammation of the gut wall. For this discussion, we will be focusing on ulcerative colitis (UC) and Crohn’s disease (CD). The main differences between the two are that ulcerative colitis mainly involves the large intesti...

Inflammatory bowel disease (IBD) is a group of conditions that affect the gastrointestinal system. IBD consists of autoimmune diseases that attack the GI mucosa, resulting in inflammation of the gut wall. For this discussion, we will be focusing on ulcerative colitis (UC) and Crohn’s disease (CD). The main differences between the two are that ulcerative colitis mainly involves the large intesti...

Rheumatological manifestations in inflammatory bowel disease (IBD) are frequent and include peripheral arthritis, axial involvement and peripheral enthesitis. Secondary osteoporosis and hypertrophic osteoarthropathy may also occur. Complications of IBD (e.g. septic arthritis) must be distinguished from sterile inflammation. Adverse effects of corticosteroid treatment, such as osteonecrosis, may...

Inflammatory bowel disease (IBD) is a group of conditions that affect the gastrointestinal system. IBD consists of autoimmune diseases that attack the GI mucosa, resulting in inflammation of the gut wall. For this discussion, we will be focusing on ulcerative colitis (UC) and Crohn’s disease (CD). The main differences between the two are that ulcerative colitis mainly involves the large intesti...